David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
B
901
CALL
Barrick Mining
B
$80.4B
| $9.1M | 0.02% |
670,200
+331,500
| +98% | +$3.86M |
|
|
HMHC
902
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $9.08M | 0.02% |
455,471
-177,519
| -28% | -$3.27M |
|
|
DDC
903
DELISTED
Dominion Diamond Corporation
DDC
| $9.08M | 0.02% |
818,809
-16,095
| -2% | -$176K |
|
904
Ball Corp
BALL
$17B
| $9.08M | 0.02% |
254,656
-75,062
| -23% | -$2.56M |
|
905
CALL
Constellation Brands
STZ
$23.1B
| $9.06M | 0.02% |
60,000
+4,400
| +8% | +$636K |
|
|
NCI
906
DELISTED
Navigant Consulting, Inc.
NCI
| $9.03M | 0.02% |
570,910
+118,310
| +26% | +$1.81M |
|
|
DFS
907
DELISTED
Discover Financial Services
DFS
| $9.02M | 0.02% |
+177,222
| New | +$8.54M |
|
908
PUT
NOV
NOV
$7.11B
| $9.02M | 0.02% |
290,000
-27,800
| -9% | -$849K |
|
|
B
909
PUT
Barrick Mining
B
$80.4B
| $8.96M | 0.02% |
659,800
-1,045,000
| -61% | -$12.2M |
|
910
PUT
CSX Corp
CSX
$95.4B
| $8.95M | 0.02% |
1,043,100
+161,700
| +18% | +$1.31M |
|
911
Expro Ltd
XPRO
$1.98B
| $8.95M | 0.02% |
90,535
-12,557
| -12% | -$1.09M |
|
912
Curtiss-Wright
CW
$22.5B
| $8.94M | 0.02% |
+118,187
| New | +$8.2M |
|
913
Bread Financial
BFH
$4.14B
| $8.93M | 0.02% |
50,834
+23,823
| +88% | +$4.16M |
|
914
Spire
SR
$4.92B
| $8.92M | 0.02% |
131,664
+6,846
| +5% | +$436K |
|
|
PMC
915
DELISTED
PharMerica Corporation
PMC
| $8.92M | 0.02% |
403,403
-54,954
| -12% | -$1.46M |
|
916
CALL
Southwest Airlines
LUV
$20B
| $8.88M | 0.02% |
198,300
+98,100
| +98% | +$3.99M |
|
917
PUT
Eaton
ETN
$159B
| $8.88M | 0.02% |
141,900
-4,300
| -3% | -$238K |
|
918
Ribbon Communications
RBBN
$368M
| $8.8M | 0.02% |
1,169,032
+492,661
| +73% | +$3.29M |
|
919
Toll Brothers
TOL
$13.9B
| $8.79M | 0.02% |
+297,896
| New | +$8.33M |
|
920
Smith & Wesson
SWBI
$606M
| $8.77M | 0.02% |
428,672
-170,514
| -28% | -$3.17M |
|
921
Steel Dynamics
STLD
$33.1B
| $8.71M | 0.02% |
386,704
+104,276
| +37% | +$1.97M |
|
922
Chord Energy
CHRD
$7.7B
| $8.7M | 0.02% |
1,195,127
-549,145
| -31% | -$3.28M |
|
923
CALL
Royal Caribbean
RCL
$78.2B
| $8.7M | 0.02% |
105,900
+30,000
| +40% | +$2.34M |
|
924
PUT
Palo Alto Networks
PANW
$277B
| $8.7M | 0.02% |
319,800
-332,400
| -51% | -$8.17M |
|
925
Bio-Rad Laboratories Class A
BIO
$10.4B
| $8.65M | 0.02% |
63,264
+24,363
| +63% | +$3.2M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.